Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases

Clinical trial NCT06428188 · RECRUITING

Trial details

NCT number: NCT06428188
Sponsor: Essen Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Autoimmune Diseases Systemic Lupus Erythematosus Systemic Lupus Erythematosus Acute Sjogren's Syndrome

Start date: 2024-05-29
Primary completion: 2025-12-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.